These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 23626769)
1. Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats. Fang CB; Zhou DX; Zhan SX; He Y; Lin Z; Huang C; Li J PLoS One; 2013; 8(4):e62071. PubMed ID: 23626769 [TBL] [Abstract][Full Text] [Related]
2. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats]. Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771 [TBL] [Abstract][Full Text] [Related]
3. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6. Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis. Keino H; Watanabe T; Sato Y; Niikura M; Wada Y; Okada AA Arthritis Res Ther; 2008; 10(5):R122. PubMed ID: 18847496 [TBL] [Abstract][Full Text] [Related]
5. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU). Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639 [TBL] [Abstract][Full Text] [Related]
6. [Effects of exogenous interleukin-2, interleukin-23 on differentiation of IRBP 1-20-specific T cells toward Th1 and Th17 and comparison of the pathogenicity of IRBP 1-20-specific T cells]. Li Y; Cui Y; Bi HS; Wang Y; Li J; Wang XR Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):224-9. PubMed ID: 23866703 [TBL] [Abstract][Full Text] [Related]
7. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells. Bing SJ; Lyu C; Xu B; Wandu WS; Hinshaw SJ; Furumoto Y; Caspi RR; Gadina M; Gery I Mol Vis; 2020; 26():641-651. PubMed ID: 33088168 [TBL] [Abstract][Full Text] [Related]
8. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response. Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518 [TBL] [Abstract][Full Text] [Related]
9. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis. Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378 [TBL] [Abstract][Full Text] [Related]
10. Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response. Wandu WS; Tan C; Ogbeifun O; Vistica BP; Shi G; Hinshaw SJ; Xie C; Chen X; Klinman DM; Cai H; Gery I PLoS One; 2015; 10(6):e0128906. PubMed ID: 26067490 [TBL] [Abstract][Full Text] [Related]
11. Longdan Xiegan Decoction alleviates experimental autoimmune uveitis in rats by inhibiting Notch signaling pathway activation and Th17 cell differentiation. Yin X; Qiu Y; Li Z; Guo L; Wei H; Liu B; Zhou M; Li T; Wang L; Jiang W; Bi H; Guo D Biomed Pharmacother; 2021 Apr; 136():111291. PubMed ID: 33493870 [TBL] [Abstract][Full Text] [Related]
12. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis. Keino H; Watanabe T; Sato Y; Okada AA Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis. Qin T Mol Vis; 2011; 17():3486-93. PubMed ID: 22219644 [TBL] [Abstract][Full Text] [Related]
15. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells. Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946 [TBL] [Abstract][Full Text] [Related]
17. Leflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis rats. Robertson SM; Lang LS Agents Actions; 1994 Oct; 42(3-4):167-72. PubMed ID: 7879705 [TBL] [Abstract][Full Text] [Related]
18. Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats. Yadav UC; Shoeb M; Srivastava SK; Ramana KV Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8033-41. PubMed ID: 21900376 [TBL] [Abstract][Full Text] [Related]
19. Effect of type I interferon on experimental autoimmune uveoretinitis in rats. Okada AA; Keino H; Fukai T; Sakai J; Usui M; Mizuguchi J Ocul Immunol Inflamm; 1998 Dec; 6(4):215-26. PubMed ID: 9924918 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis. Takeuchi M; Yokoi H; Tsukahara R; Sakai J; Usui M Jpn J Ophthalmol; 2001; 45(5):463-9. PubMed ID: 11583666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]